Skip to main navigation

Home
Products
Workflows
- Research applications
- Clinical applications
Innovation
- SOLA Technology
About
- Leadership
- Careers
- Press + news
- Distributors
- Events
- Legal
- Blog
Investors
Order
Contact

Order
Support

Investor Relations

Investors
News + events
Stock information
Corporate governance
Financials + filings
IR resources

Event Details

News & Events menu

News & Events menu

News Releases
|
Events
|
Tradeshows + Webinars
|
Presentations

Q2 2023 Telesis Bio Earnings Conference Call

August 10, 2023 4:30 PM EDT

Listen to Webcast

About Telesis Bio

Telesis Bio Inc. is building biology. Creators of the BioXp® system, the world’s only fully automated gene synthesis platform, and the industry-standard Gibson Assembly® method, Telesis Bio Inc. is focused on enabling researchers with the tools they need to rapidly and securely design, code, and create synthetic DNA.

Telesis Bio Inc. is accelerating advances in the fields of personalized medicine, biologics drug discovery, vaccine development, genome editing, and cell and gene therapy.

Site

Products
Workflows
Support
About
Investors
Order
Contact

Links

Events
Blog
Careers
Terms of use
Cookie policy
Privacy policy
Legal

© 2024 Telesis Bio Inc. All rights reserved.